Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

MLA

Zhen Yuan, et al. “Pegylated Liposomal Doxorubicin in Patients with Epithelial Ovarian Cancer.” Journal of Ovarian Research, vol. 14, no. 1, Jan. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13048-020-00736-2.

APA

Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng, Guiling Li, Changzhong Li, Huirong Shi, & Yaqing Chen. (2021). Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer. Journal of Ovarian Research, 14(1), 1–13. https://doi.org/10.1186/s13048-020-00736-2

Chicago

Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, et al. 2021. “Pegylated Liposomal Doxorubicin in Patients with Epithelial Ovarian Cancer.” Journal of Ovarian Research 14 (1): 1–13. doi:10.1186/s13048-020-00736-2.